Today, Allergan Aesthetics announced the FDA approval of brand-new SKINVIVE by JUVÉDERM to improve skin smoothness in adults over the age of 21. “SKINVIVE by JUVÉDERM is the first and only intradermal microdroplet injection for skin smoothness available in the U.S. with results lasting through six months with optimal treatment,” the release reads.
While it may be joining Juvéderm’s expansive collection of fillers, SKINVIVE is quite different in both form and function. SKINVIVE is a smooth, injectable hyaluronic acid (HA) gel that contains a small amount of local anesthetic (lidocaine). Unlike other HA-powered injectables that enhance and augment the treatment area, SKINVIVE by JUVÉDERM improves skin quality in the cheeks by smoothing the skin and increasing hydration. The result: more radiant-looking skin.
Per the release, the smooth, hydrating gel flows easily into the skin and is approved for all Fitzpatrick Skin Types I-VI, a key differentiator that addresses an important unmet need in the skin quality category, the brand notes. “Treatment is minimally invasive, offers little to no downtime, and provides results over the course of six months without requiring a recurring series of treatments.”
“SKINVIVE by JUVÉDERM is a new frontier in injectable devices used for skin quality,” explains San Diego dermatologist Melanie Palm, MD. “Unlike any other treatment on the market, it is the first and only intradermal microdroplet injection approved in the US to improve skin smoothness.”
Dr. Palm continues, “The clinical trials for SKINVIVE by JUVÉDERM demonstrate marked improvements in skin hydration and radiance that lasts through six months, filling an unmet need for patients desiring long-term improvements in skin quality beyond what topical skin-care products can achieve.”
According to Carrie Strom, president, Global Allergan Aesthetics and senior vice president, AbbVie, “SKINVIVE by JUVÉDERM is a category-creating HA product that leaves skin looking healthier, more glowing, and more hydrated. This unique product is a result of our vast experience in HA science and complements our current collection of HA products, with the JUVÉDERM Collection of Fillers and SkinMedica topicals.”
SKINVIVE by JUVÉDERM is a groundbreaking addition to the world of injectables, addressing an unmet need in the skin-quality category. Its unique ability to improve skin smoothness and hydration for up to six months without recurring treatments makes it an appealing option for those seeking long-term improvements in their skin quality.
